Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects. myarzi12019-03-26T13:19:12+00:00Netazepide| Read More
Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects. myarzi12019-03-26T13:19:44+00:00Netazepide| Read More
The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression. myarzi12019-03-26T13:20:31+00:00Netazepide| Read More
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. training2019-03-26T13:22:08+00:00GNETs, Netazepide| Read More